Carbohydrate and lipid oxidation was measured in normal and diabetic human beings by means of continuous indirect calori metry in the course of a 100-gm. oral glucose tolerance test. After the glucose load, the carbohydrate (CHO) oxidation rate of 10 control subjects gradually rose, from 30 to 180 minutes, during the decline of plasma glucose and immunoreactive insulin (IRI). The lipid oxidation rate decreased during the same period. Diabetics were divided into two groups. In a group of six nonobese maturity-onset diabetics with a slight IRI response to glucose load and a fall in plasma free fatty acid (FFA) levels, the CHO oxidation rate was found to be of the same order of magnitude as in normal subjects, but this occurred at a high plasma concentration of glucose. The lipid oxidation rate decreased as in normal subjects. Conversely, in a group of four juvenile-type diabetics with no IRI response to glucose load and no fall in FFA levels, the CHO oxidation rate was markedly diminished and the lipid oxidation rate presented only a slight fall after glucose load. In the group of maturity-onset diabetics, a slight insulin secretion seemed to be sufficient to prevent lipolysis and to allow normal rates of lipid and CHO oxidation in response to glucose load. On the other hand, in the group of juvenile-type diabetics, the lack of endogenous insulin secretion seemed to be responsible for increased lipolysis, leading to decreased responses of lipid and CHO oxidation to glucose load.
Oral tolerance tests with 30 and 50 g of xylitol were performed in 10 normal subjects adapted to taking this pentitol. A 50 g oral glucose tolerance test served as control. Continuous indirect calorimetry was carried out in 7 of these subjects to measure the effects on the metabolic rate and on the oxidation rates of carbohydrate and fat. A small and short rise in serum xylitol and low quantities of xylitol excretion in urine were observed in both xylitol tests. Xylitol caused a small but statistically significant increase in blood glucose and plasma insulin concentrations. Plasma free glycerol diminished significantly. After xylitol the metabolic rate rose throughout the test period but the total increase was only half of that after glucose administration. There was no significant influence of xylitol on the oxidation rates of carbohydrate and lipids. The total increase in carbohydrate oxidation during 2/2 hours amounted to one fourth of that caused by glucose. It is suggested that xylitol, during the first two hours after ingestion, charges the body’s metabolism much less than equal amounts of glucose. Therefore, the use of xylitol as a sweetener in the diet of diabetic patients seems to be justified.
The influence of peripherally administered adrenaline on the secretion of human growth hormone (HGH) and cortisol was investigated in 14 normal subjects. In a control group, HGH and cortisol release was stimulated by insulin infusion for 30 min (0.1 IU/kg). This procedure was compared with a similar insulin infusion which was started 60 min after initiating an adrenaline infusion for 150 min (6 μg/min). Adrenaline did not significantly alter the basal levels of HGH and cortisol. The mean maximal HGH rise during insulin hypoglycaemia (38.9 ± 7.2 ng/ml) was significantly (P < 0.005) inhibited by simultaneously administered adrenaline (9.6 ± 3.0 ng/ml). The same action of adrenaline was also found to be effective on cortisol release. The rise in plasma cortisol after insulin infusion (16.0±1.4 μg/100ml) was suppressed by adrenaline to 6.4 ± 2.2μg/100 ml (P < 0.005). Blood glucose and plasma free fatty acids (FFA), increased by adrenaline administration, were decreased significantly after insulin infusion. These results suggest an inhibitory effect of peripheral adrenaline on insulin-induced secretion of HGH. Blood glucose and plasma FFA levels seem to have no effect on this action. Whether there is a negative feedback between HGH and adrenaline should be considered. It is possible that the inhibition of cortisol release by adrenaline is mediated by an inhibiting effect on ACTH release, in the same manner as on the release of HGH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.